275 related articles for article (PubMed ID: 17187006)
21. Hyperprolactinemia associated with psychotropics--a review.
Madhusoodanan S; Parida S; Jimenez C
Hum Psychopharmacol; 2010; 25(4):281-97. PubMed ID: 20521318
[TBL] [Abstract][Full Text] [Related]
22. The relationship between prolactin response and clinical efficacy of risperidone in acute psychotic inpatients.
Lee BH; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):658-62. PubMed ID: 16466670
[TBL] [Abstract][Full Text] [Related]
23. The effect of the Taq1A variant in the dopamine D₂ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys.
Roke Y; van Harten PN; Franke B; Galesloot TE; Boot AM; Buitelaar JK
Pharmacogenet Genomics; 2013 Sep; 23(9):487-93. PubMed ID: 23851570
[TBL] [Abstract][Full Text] [Related]
24. Prolactin release in children treated with risperidone: impact and role of CYP2D6 metabolism.
Troost PW; Lahuis BE; Hermans MH; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ
J Clin Psychopharmacol; 2007 Feb; 27(1):52-7. PubMed ID: 17224713
[TBL] [Abstract][Full Text] [Related]
25. The effect of smoking status on the plasma concentration of prolactin already elevated by risperidone treatment in schizophrenia patients.
Ohta C; Yasui-Furukori N; Furukori H; Tsuchimine S; Saito M; Nakagami T; Yoshizawa K; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):573-6. PubMed ID: 21216266
[TBL] [Abstract][Full Text] [Related]
26. Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia.
Yasui-Furukori N; Furukori H; Sugawara N; Fujii A; Kaneko S
J Clin Psychopharmacol; 2010 Oct; 30(5):596-9. PubMed ID: 20814333
[TBL] [Abstract][Full Text] [Related]
27. Management of psychotropic-induced hyperprolactinemia.
Marken PA; Haykal RF; Fisher JN
Clin Pharm; 1992 Oct; 11(10):851-6. PubMed ID: 1341991
[TBL] [Abstract][Full Text] [Related]
28. Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study.
Cavallaro R; Cocchi F; Angelone SM; Lattuada E; Smeraldi E
J Clin Psychiatry; 2004 Feb; 65(2):187-90. PubMed ID: 15003071
[TBL] [Abstract][Full Text] [Related]
29. Comparison of prolactin concentrations between haloperidol and risperidone treatments in the same female patients with schizophrenia.
Yasui-Furukori N; Kondo T; Suzuki A; Mihara K; Kaneko S
Psychopharmacology (Berl); 2002 Jun; 162(1):63-6. PubMed ID: 12107619
[TBL] [Abstract][Full Text] [Related]
30. [Galactorrhea and secondary amenorrhea in hyperprolactinemia].
Wallmeroth A; Staub JJ
Praxis (Bern 1994); 2000 Aug; 89(34):1341-3. PubMed ID: 11021189
[No Abstract] [Full Text] [Related]
31. Elevated prolactin levels in male youths treated with risperidone and quetiapine.
Stevens JR; Kymissis PI; Baker AJ
J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):893-900. PubMed ID: 16379509
[TBL] [Abstract][Full Text] [Related]
32. Amenorrhoea - consequence of combined treatment with sulpiride and risperidone in a patient suffering from schizophrenia.
Peitl MV; Pavlović E; Peitl A; Peitl V
Psychiatr Danub; 2010 Mar; 22(1):123-4. PubMed ID: 20305607
[TBL] [Abstract][Full Text] [Related]
33. How to manage anxious patients who are depressed.
Sussman N
J Clin Psychiatry; 1993 May; 54 Suppl():8-16; discussion 17-20. PubMed ID: 8099581
[TBL] [Abstract][Full Text] [Related]
34. Hyperprolactinaemia with amisulpride.
Ružić K; Grahovac T; Graovac M; Dadić-Hero E; Sepić-Grahovac D; Sabljić V
Psychiatr Danub; 2011 Mar; 23(1):92-4. PubMed ID: 21448106
[TBL] [Abstract][Full Text] [Related]
35. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection.
Bai YM; Chen TT; Lin WK; Chang WH; Wu B; Hung CH; Chou P; Chen JY
J Clin Psychopharmacol; 2007 Jun; 27(3):306-8. PubMed ID: 17502783
[No Abstract] [Full Text] [Related]
37. Antipsychotic-induced hyperprolactinemia.
Bostwick JR; Guthrie SK; Ellingrod VL
Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
[TBL] [Abstract][Full Text] [Related]
38. Relationship between prolactin secretion, and plasma risperidone and 9-hydroxyrisperidone concentrations in adolescents with schizophreniform disorder.
Duval F; Guillon MS; Mokrani MC; Crocq MA; Garcia Duarte F
Psychoneuroendocrinology; 2008 Feb; 33(2):255-9. PubMed ID: 18053652
[TBL] [Abstract][Full Text] [Related]
39. Antidepressant combination therapy of endogenous depressions with benzodiazepines or neuroleptics--a study comparing adjuvant treatment with oxazolam versus chlorprothixene.
Laux G; Koenig W; Pfaff G
Pharmacopsychiatry; 1988 Mar; 21(2):87-92. PubMed ID: 2899329
[TBL] [Abstract][Full Text] [Related]
40. Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients.
Yasui-Furukori N; Saito M; Tsuchimine S; Nakagami T; Sato Y; Sugawara N; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1491-5. PubMed ID: 18579277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
